Literature DB >> 32981921

Is Oxidative Stress a Key Player for Progression of Cardiovascular Disease in Dialysis Patients?

Hideki Fujii1.   

Abstract

Entities:  

Year:  2020        PMID： 32981921      PMCID： PMC8048950          DOI： 10.5551/jat.ED145

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  8 in total

1.  Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction.

Authors:  Hideki Fujii; Yuriko Yonekura; Yusuke Yamashita; Keiji Kono; Kentaro Nakai; Shunsuke Goto; Mikio Sugano; Sumie Goto; Ayako Fujieda; Yoshiharu Ito; Shinichi Nishi
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

Review 2.  Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients.

Authors:  Maurizio Bossola; Luigi Tazza
Journal:  Semin Dial       Date:  2015-01-11       Impact factor: 3.455

3.  Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

Authors:  Dick de Zeeuw; Tadao Akizawa; Paul Audhya; George L Bakris; Melanie Chin; Heidi Christ-Schmidt; Angie Goldsberry; Mark Houser; Melissa Krauth; Hiddo J Lambers Heerspink; John J McMurray; Colin J Meyer; Hans-Henrik Parving; Giuseppe Remuzzi; Robert D Toto; Nosratola D Vaziri; Christoph Wanner; Janet Wittes; Danielle Wrolstad; Glenn M Chertow
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

4.  Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation.

Authors:  Ken Kitamura; Hideki Fujii; Kentaro Nakai; Keiji Kono; Shunsuke Goto; Tatsuya Nishii; Atsushi Kono; Shinichi Nishi
Journal:  Heart Vessels       Date:  2017-03-21       Impact factor: 2.037

5.  Bardoxolone methyl and kidney function in CKD with type 2 diabetes.

Authors:  Pablo E Pergola; Philip Raskin; Robert D Toto; Colin J Meyer; J Warren Huff; Eric B Grossman; Melissa Krauth; Stacey Ruiz; Paul Audhya; Heidi Christ-Schmidt; Janet Wittes; David G Warnock
Journal:  N Engl J Med       Date:  2011-06-24       Impact factor: 91.245

6.  Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.

Authors:  Hideki Fujii; Fuyuhiko Nishijima; Sumie Goto; Mikio Sugano; Hideyuki Yamato; Riko Kitazawa; Sohei Kitazawa; Masafumi Fukagawa
Journal:  Nephrol Dial Transplant       Date:  2009-02-02       Impact factor: 5.992

7.  Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study).

Authors:  Masaomi Nangaku; Hironori Kanda; Hirotaka Takama; Tomohiro Ichikawa; Hiroki Hase; Tadao Akizawa
Journal:  Kidney Int Rep       Date:  2020-04-14

8.  Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort.

Authors:  Keyaki Sasaki; Tetsuo Shoji; Daijiro Kabata; Ayumi Shintani; Yujiro Okute; Shoko Tsuchikura; Naoko Shimomura; Yoshihiro Tsujimoto; Shinya Nakatani; Katsuhito Mori; Atsushi Shioi; Masaaki Inaba; Masanori Emoto
Journal:  J Atheroscler Thromb       Date:  2020-08-01       Impact factor: 4.928
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.